GABA Biomarkers in Dravet Syndrome Study
This study is looking at levels of GABA (a brain chemical that helps calm nerve activity) in children with Dravet Syndrome and healthy children. Researchers will collect blood samples to measure GABA levels. They will also use non-invasive brain tests to see if these measures can help understand how GABA works in Dravet Syndrome. The goal is to find new ways to monitor GABA levels in the brain, which could help guide future treatments. The study is open to all genders, from birth to 18 years old. We don't have information on the current recruitment status.
- Study design
- This is an observational study, meaning participants will be observed without receiving new treatments. It plans to enroll 36 participants.
- What's involved
- You would have blood specimens collected by a registered phlebotomist.
- Compensation
- Not stated in the trial record.
- Follow-up
- GABA blood levels will be measured up to 30 minutes after collection.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
GABA Biomarkers in Dravet Syndrome
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Christos Papadelis, PhD · PRINCIPAL_INVESTIGATOR · Cook Children's Health Care System
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- GABA Blood LevelUp to 30 minutes
GABA levels evaluated by clinical blood draw.